NCT00435526View on ClinicalTrials.gov

Efficacy of Anti-CFA/I and CfaE Bovine Milk Immunoglobulin Against Challenge With H10407 ETEC Expressing CFA/I

PHASE1CompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

March 31, 2006

Study Completion Date

October 31, 2006

Conditions
Diarrhea
Interventions
BIOLOGICAL

anti-CFA/I bovine IgG, and anti-CfaE bovine IgG

Trial Locations (2)

21224

Johns Hopkins Bayview Medicial Center, Inpatient Unit, Baltimore

21287

General Clinical Research Center, Baltimore

Sponsors
All Listed Sponsors
collaborator

Naval Medical Research Center

FED

collaborator

Walter Reed Army Institute of Research (WRAIR)

FED

lead

Johns Hopkins Bloomberg School of Public Health

OTHER

NCT00435526 - Efficacy of Anti-CFA/I and CfaE Bovine Milk Immunoglobulin Against Challenge With H10407 ETEC Expressing CFA/I | Biotech Hunter | Biotech Hunter